Medicare Enrolled
Dr. Victor Aviles, MD
Hematology & Oncology · North Falmouth, MA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Aviles from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aviles?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aviles
Dr. Victor Aviles is a hematology & oncology specialist in North Falmouth, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Aviles performed 183,802 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Aviles received a total of $621 from 13 pharmaceutical and/or device companies across 24 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aviles is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 0% volume in MA
$621 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗183,802
Medicare services
Top 0% in MA for hematology & oncology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
108,630 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 24,200 | $43 | $86 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
14,251 | $0 | $4 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
11,460 | $6 | $36 |
| Denosumab injection (Prolia/Xgeva) | 8,940 | $18 | $40 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,363 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,491 | $8 | $57 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,240 | $1 | $55 |
| Anti-nausea injection (ondansetron/Zofran) | 1,204 | $0 | $15 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
1,149 | $1 | $6 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,085 | $8 | $75 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
916 | $99 | $300 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
900 | $82 | $550 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
720 | $68 | $160 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
675 | $11 | $75 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
550 | $13 | $70 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
409 | $111 | $531 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
257 | $2 | $18 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
252 | $54 | $290 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
235 | $28 | $290 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
205 | $25 | $110 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
200 | $145 | $400 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
127 | $22 | $60 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
109 | $20 | $60 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
109 | $1 | $10 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 105 | $134 | $1,278 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
98 | $1 | $11 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
96 | $55 | $180 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
88 | $17 | $43 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
74 | $11 | $86 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
74 | $28 | $110 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
71 | $16 | $75 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
68 | $24 | $117 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
62 | $32 | $150 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
62 | $77 | $205 |
| Refilling and maintenance of portable pump This service involves refilling and performing maintenance on a portable pump. |
56 | $108 | $503 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
53 | $60 | $150 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
52 | $218 | $375 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
49 | $118 | $350 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
47 | $47 | $380 |
| New patient office visit, complex (60-74 min) | 41 | $182 | $400 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
15 | $31 | $45 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
14 | $33 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
60.6% high complexity
36.7% medium
2.8% routine
Industry Payment Transparency
Open Payments through 2022 ↗$621
Total received (2018-2022)
Avg $155/year across 4 years
Bottom 48% in MA for hematology & oncology
13
Companies
24
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2022
$291
2021
$48
2020
$34
2018
$249
Payments by company (2022)
Novocure GmbH
$200
GENZYME CORPORATION
$39
E.R. Squibb & Sons, L.L.C.
$34
Celgene Corporation
$18
Top 3 companies account for 93.9% of 2022 payments
All-time payments by company (2018-2022) ›
Novocure GmbH
$200
E.R. Squibb & Sons, L.L.C.
$119
Merck Sharp & Dohme Corporation
$59
Celgene Corporation
$53
GENZYME CORPORATION
$39
Lilly USA, LLC
$35
Eisai Inc.
$22
Janssen Biotech, Inc.
$21
Pharmacyclics LLC, An AbbVie Company
$16
AstraZeneca Pharmaceuticals LP
$16
BeiGene USA, Inc.
$15
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Gilead Sciences, Inc.
$12
Top 3 companies account for 60.8% of all-time payments
Associated products mentioned in payments ›
ALIMTA · Abraxane · BRUKINSA · Erleada · FASLODEX · GILOTRIF · Halaven · INREBIC · Imbruvica · JEVTANA · KEYTRUDA · OPDIVO · Pomalyst · SPRYCEL · VERZENIO
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
13
County median income
$94,452
Nearest hospital to ZIP centroid (approximate)
CAPE COD & ISLANDS COMMUNITY MENTAL HEALTH CENTER
3.5 mi
3.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2022 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Aviles is a mixed practice specialist, with above-average Medicare volume (top 0% in MA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Aviles experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Aviles performed 108,630 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Aviles receive payments from pharmaceutical companies?
Yes. Dr. Aviles received a total of $621 from 13 companies across 24 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aviles's costs compare to other hematology & oncology specialists in North Falmouth?
Dr. Aviles's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aviles) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in North Falmouth
Browse hematology & oncology specialists in North Falmouth ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in MA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in MA
Which MA hematology & oncology specialists receive the most from drug and device companies.
By company
Novocure GmbH Payments to Doctors
See all physicians who received payments from Novocure GmbH.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology